Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer
- 1 August 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (12) , 1889-1896
- https://doi.org/10.1016/j.ejca.2006.01.058
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survivalEuropean Journal Of Cancer, 2004
- Clinical utility of biochemical markers in colorectal cancerEuropean Journal Of Cancer, 2003
- In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.Journal of Clinical Investigation, 1998
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Is follow-up of colorectal cancer patients worthwhile?Diseases of the Colon & Rectum, 1993
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumoursInternational Journal of Cancer, 1991
- The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activityBiochemistry, 1991
- Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityNature, 1985
- The classification of cancer of the rectumThe Journal of Pathology and Bacteriology, 1932